Xeal
About Gelato #33
G33HybridCured properly, flowers of Gelato have a predominant smell of pungent citrus, compliments of fruity parent strain Sunset Sherbert.
Bred by 
Sherbinskis
Gelato is a hybrid crossed from taste-engineered parents Thin Mint Girl Scout Cookies and fruity indica Sunset Sherbert. With a balanced, mellow high and a universally appealing flavor profile, this is a great strain for social use. San Francisco creators Cookie Fam Genetics have released multiple numbered phenotypes of Gelato - phenotype #33 has picked up the nickname Larry Bird in reference to the legendary player’s jersey number. This strain has an indica-leaning high and carries a THC composition that ranges from 20% to 25%.
Gelato’s buds tend to be small but they have the thick and dense structure characteristic of many indica varieties. This is a strain with immediate visual appeal: bright orange pistils stand out against forest green leaves that are accented by shades of deep purple. The purple hues come about when high concentrations of pigments called anthocyanins are stimulated by cold weather in the vegetative stage. Although the buds themselves are sticky, short stalks on the trichomes mean that this strain has a less frosty appearance than many others. Cured properly, flowers of Gelato have a predominant smell of pungent citrus, compliments of fruity parent strain Sunset Sherbert. Notes of yeast and dough can be detected as well.
Grinding up or breaking apart the flowers gives off a more herbal, earthy profile.
Description provided by Wikileaf.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Glass Pharms Ltd.
EcoCann by Glass Pharms, the first UK commercial licence granted by the Home Office to supply high-THC cannabis flower to lawful third parties, such as pharmaceutical companies.
Glass Pharms cultivate for the UK medicines market. This requires us to grow to exacting British standards for both compliance and quality. We supply year round to meet the demand of UK patient needs with fanatical quality assurance and local accountability. Currently, almost all medical cannabis that is supplied to patients in the UK is imported, with inconsistency of quality and supply.
Glass Pharms have the first UK commercial licence granted by the Home Office to supply High-THC cannabis flower to lawful third parties, such as pharmaceutical companies. This will allow the company to grow medical cannabis to the correct regulatory standards for onward supply to UK pharmacies and clinics.
We never lose sight of the fact that our products are intended for use by patients and we listen to their needs. Our cultivation is clinician-led and we use precision chemotypes that have proven efficacy in the real world. World leading biosecurity and testing ensure our products are free from contaminants like heavy metals, fungi and mould.
British-based cultivation means no added importation costs, or supply chain issues for medicines created from our products, enabling cost savings to be passed on to patients.
Consistency is key in growing plants for use in human medicines. In our proprietary cultivation process, more than 10 different growing factors are controlled for using AI. This extraordinary control over conditions means that the end product is consistent time and time again. We use the latest in energy efficient agricultural glasshouse technology and innovation from our partners in the Netherlands, combined with British scientific know-how to ensure world-leading results.
glasspharms.com
Further National Health-Service Information on